These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3841498

  • 1. The NIH Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer--a commentary.
    Lippman ME.
    Breast Cancer Res Treat; 1985; 6(3):195-200. PubMed ID: 3841498
    [No Abstract] [Full Text] [Related]

  • 2. National Institutes of Health Consensus Development Conference Statement: Adjuvant Chemotherapy for Breast Cancer. September 9-11, 1985.
    CA Cancer J Clin; 1986; 36(1):42-7. PubMed ID: 3080207
    [No Abstract] [Full Text] [Related]

  • 3. [Breast cancer adjuvants: results of a DUR (drug utilization research) study].
    Nuzzo A.
    Suppl Tumori; 2004; 3(4):S86-7. PubMed ID: 15206223
    [No Abstract] [Full Text] [Related]

  • 4. The present status of the adjuvant endocrine treatment.
    Jonat W, Maass H.
    J Steroid Biochem; 1987; 27(1-3):499-502. PubMed ID: 3320540
    [Abstract] [Full Text] [Related]

  • 5. Is adjuvant tamoxifen recommended in post-menopausal node-negative breast cancer patients with high estrogen receptor values?
    Floiras JL, Hacene K, Turpin F, Spyratos F.
    Int J Biol Markers; 2000; 15(2):135-8. PubMed ID: 10883886
    [Abstract] [Full Text] [Related]

  • 6. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD.
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract] [Full Text] [Related]

  • 7. Tamoxifen or aromatase inhibitors in breast cancer: efficacy and safety.
    Neven P, Van Den Broecke R.
    Acta Chir Belg; 2007 Jun; 107(3):240-56. PubMed ID: 17685248
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adjuvant systemic therapy of breast cancer.
    Lippman ME.
    Important Adv Oncol; 1985 Jun; ():254-72. PubMed ID: 3916744
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Déjà vu for breast cancer two?
    Stearns V, Davidson NE.
    J Natl Cancer Inst; 2004 Apr 07; 96(7):497-9. PubMed ID: 15069104
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problem.
    Schott A, Hayes DF.
    J Clin Oncol; 2004 Dec 01; 22(23):4660-2. PubMed ID: 15505274
    [No Abstract] [Full Text] [Related]

  • 14. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.
    Rose C, Thorpe SM, Andersen KW, Pedersen BV, Mouridsen HT, Blichert-Toft M, Rasmussen BB.
    Lancet; 1985 Jan 05; 1(8419):16-9. PubMed ID: 2856949
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Are current worldwide studies going to answer the important questions remaining in adjuvant chemotherapy of breast cancer?
    Brunner KW.
    Recent Results Cancer Res; 1984 Jan 05; 96():224-36. PubMed ID: 6396778
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
    Rosso R, Boccardo F, Brema F, Sertoli MR, Amoroso D, Bertelli G, Pronzato P.
    Anticancer Res; 1989 Jan 05; 9(4):1153-6. PubMed ID: 2817796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.